Abstract

This project is central to the Conte center. All other projects are linked to this project in a conceptualand a practical sense. This project follows up on our findings that lesions disrupt the functioning ofthe mood circuit in elderly patients with depression. The project utilizes multimodal imaging Diffusiontensor imaging (DTI), magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS)along with cognitive testing and genetics to study the connectivity and dysregulation of the moodcircuit. Based on findings from our earlier work we evaluate the nature of the changes in the fibertracts connecting amygdala, Orbital prefrontal cortex, dorsolateral prefrontal cortex, striatum and itsrelationship to neurocognitive changes. We evaluate whether glutamate isreduced in the anterior cingulate and orbital prefrontal cortex in patients with depression using MRS.In addition we evaluate changes in brain structure and function as it relates to serotonin transporterpromoter region allelic variants. This project uses state of the art image processing and will lead to agreater understanding of the neuroanatomical substrates of depression.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center (P50)
Project #
2P50MH060451-06
Application #
7167301
Study Section
Special Emphasis Panel (ZMH1-ERB-L (04))
Project Start
2006-07-01
Project End
2011-06-30
Budget Start
2006-07-01
Budget End
2007-07-31
Support Year
6
Fiscal Year
2006
Total Cost
$340,841
Indirect Cost

  Institution

Name
Duke University
Department
Type
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705

  Publications

Petyuk, Vladislav A; Chang, Rui; Ramirez-Restrepo, Manuel et al. (2018) The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain 141:2721-2739
Sims, Rebecca (see original citation for additional authors) (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet 49:1373-1384
Jun, Gyungah R; Chung, Jaeyoon; Mez, Jesse et al. (2017) Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement 13:727-738
Hohman, Timothy J; Bush, William S; Jiang, Lan et al. (2016) Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium. Neurobiol Aging 38:141-150
Jun, G; Ibrahim-Verbaas, C A; Vronskaya, M et al. (2016) A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry 21:108-17
Jacobsen, Jacob Pr; Rudder, Meghan L; Roberts, Wendy et al. (2016) SSRI Augmentation by 5-Hydroxytryptophan Slow Release: Mouse Pharmacodynamic Proof of Concept. Neuropsychopharmacology 41:2324-34
Ebbert, Mark T W; Boehme, Kevin L; Wadsworth, Mark E et al. (2016) Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk. Alzheimers Dement 12:121-129
Hohman, Timothy J; Cooke-Bailey, Jessica N; Reitz, Christiane et al. (2016) Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk. Alzheimers Dement 12:233-43
Saha, Sayoni; Hatch, Daniel J; Hayden, Kathleen M et al. (2016) Appetite and Weight Loss Symptoms in Late-Life Depression Predict Dementia Outcomes. Am J Geriatr Psychiatry 24:870-8
Jacobsen, Jacob P R; Krystal, Andrew D; Krishnan, K Ranga R et al. (2016) Adjunctive 5-Hydroxytryptophan Slow-Release for Treatment-Resistant Depression: Clinical and Preclinical Rationale. Trends Pharmacol Sci 37:933-944

Showing the most recent 10 out of 250 publications